INS and Alzheimer disease: Once islets are coated with AD-MSCs, we found they exhibited an enhanced secretion of insulin in response to glucose challenges as well as improved survival in vitro which we attributed to the ability of AD-MSCs to secrete trophic and growth factors [10, 46] as well as increase the insulin sensitivity of islets [53].